This product includes the webinar and CME/CMLE credit


Speaker

Lynette M. Sholl, MD

Moderator

Christina Lockwood, PhD

Description: This session will focus on the principles of cell free DNA biology and approaches to detecting genomic alterations in circulating tumor DNA relevant to the diagnosis and management of solid tumor patients. Areas of controversy, as well as technical developments that may expand the use of liquid biopsy in clinical medicine, will be addressed. 

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: December 31, 2020

Maximum CME/CMLE credit available: 1.0

This webinar is part 4 of a five-part series aimed at breaking down barriers to NSCLC testing and treatment. If you'd like more information about the series go here.

Supported by an educational grant provided by AstraZeneca


How to claim credit: To earn CME/CMLE credit, all learners must watch the webinar and then complete the online survey. To access the online survey, click "Submit credit" on the course homepage, or click on "My Credit" on the menu to the left.

AMA PRA Category 1 Credit(s)™

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity. 

* You may not submit SAMs and CME/CMLE credit for the same content.


You may also be interested in:

Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP

 
Course Information
Course Date:
October 09, 2018
Course Objectives
  • Recognize the biological and technical challenges that limit the sensitivity of liquid biopsy
  • Identify factors that may lead to discrepant results when comparing tumor genomic alterations across platforms or biopsy types
Pre-Test for Liquid Biopsies - Promises and Pitfalls (+CME/CMLE)
Liquid Biopsies - Promises and Pitfalls
Post-Test for Liquid Biopsies - Promises and Pitfalls (+CME/CMLE)
QA Session
How to Claim CME/CMLE
Individual topic purchase: Selected
American Medical Association
Continuing Medical Education: 1.00
American Society for Clinical Pathology
CMLE: 1.00
Products
Sholl (+CME/CMLE)
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $0.00